Global study shows why antidepressants work better for some

By Admin
A study conducted by British scientists finds that they have identified biological markers in the blood which should help doctors match patients to the...

A study conducted by British scientists finds that they have identified biological markers in the blood which should help doctors match patients to the best type of treatment for depression.

The aim of the study is to end the trial and error prescription of antidepressants, which is the only way the depressed patients can find the most effective treatment.

Carmine Pariante of King’s College London’s Institute of Psychiatry, who led the study said, “The study shows that we could use a blood-based test to personalize the treatment of depression.”

She and her colleagues found that high levels of inflammation which show up in biological markers in the blood are part of mechanism leading to depression.

Carmine also said, “If a patient had high levels of inflammation, they could immediately begin with a more intensive treatment programme, like combining antidepressants or stepping up the doses.” 

Nortriptyline sold under the brand names Sensoval, Aventyl and others is an older type of antidepressant known as tricyclic. These are both commonly prescribed as first line antidepressant treatments in other countries and Britain.

Post 8 weeks of treatment, researchers found that patients who were not getting any better were ones having higher levels of three inflammation markets before treatment began.

Share

Featured Articles

Snowflake: Transforming patient healthcare with Gen AI

Jesse Cugliotta, Healthcare & Life Science at Snowflake, discusses revolutionising healthcare efficiency and improving patient care with Gen AI

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

Digital Healthcare

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI

AI & ML